Office of the Commissioner of Lobbying of Canada Office of the Commissioner of Lobbying of Canada

Language selection

Registry of Lobbyists

Patented Medicine Prices Review Board (PMPRB) in Active Registrations on: 2021-08-31

Other options for searching the Registry: 12-Month Lobbying Activity Search; Advanced Registry Search; Recent Registrations; and Recent Monthly Communication Reports.

Results 51-100 of 112

  • Merck Canada Inc.
    In-house Corporation: Anna Van Acker, PRESIDENT AND MANAGING DIRECTOR
    Posted date: 2021-05-10
    Submission type: Update View updated registration
  • Canadian Generic Pharmaceutical Association (CGPA) / L'Association canadienne du médicament générique (ACMG)
    In-house Organization: JAMES KEON, PRESIDENT
    Posted date: 2021-05-07
    Submission type: Update View updated registration
  • Intellectual Property Institute of Canada / INSTITUT DE LA PROPRIÉTÉ INTELLECTUELLE DU CANADA
    In-house Organization: Adam Kingsley, Chief Executive Officer
    Posted date: 2021-05-05
    Submission type: Update View updated registration
  • Novartis Pharmaceuticals Canada Inc.
    In-house Corporation: Christian Macher, Country President & Oncology General Manager Canada
    Posted date: 2021-05-03
    Submission type: Update View updated registration
  • Vertex Pharmaceuticals (Canada) Incorporated
    In-house Corporation: Michael Siauw, General Manager – Canada
    Posted date: 2021-05-03
    Submission type: Update View updated registration
  • Lundbeck Canada Inc.
    In-house Corporation: Michal Juul Sørensen, Vice-President & General Manager, Canada
    Posted date: 2021-04-30
    Submission type: Update View updated registration
  • Innovative Medicines Canada
    Consultant: Michelle McLean, Hill+Knowlton Strategies
    Posted date: 2021-04-29
    Submission type: Update View updated registration
  • Innovative Medicines Canada
    Consultant: Don Boudria, Don Boudria Consulting Inc
    Posted date: 2021-04-28
    Submission type: New View new registration
  • Institute for Advancements in Mental Health
    In-house Organization: Mary Alberti, Chief Executive Officer
    Posted date: 2021-04-26
    Submission type: Update View updated registration
  • Canadian Pharmacists Association / Association des Pharmaciens du Canada
    Consultant (Member of the board of directors): Christine Hrudka
    Posted date: 2021-04-19
    Submission type: Update View updated registration
  • RAREi - The Canadian Forum for Rare Disease Innovators / iRARE, le Forum canadien des innovateurs spécialisés dans les maladies rares
    Consultant: Stephanie Levee, 3Sixty Public Affairs Inc.
    Posted date: 2021-04-16
    Submission type: Update View updated registration
  • Canadian Medical Association / Association médicale canadienne
    Consultant (Member of the board of directors): E. Ann Collins
    Posted date: 2021-04-15
    Submission type: Update View updated registration
  • RAREi - The Canadian Forum for Rare Disease Innovators / iRARE, le Forum canadien des innovateurs spécialisés dans les maladies rares
    Consultant: GERALD JEFFCOTT, 3Sixty Public Affairs
    Posted date: 2021-04-08
    Submission type: Update View updated registration
  • Food, Health & Consumer Products of Canada / Produits alimentaires, de santé et de consommation du Canada
    In-house Organization: Michael Graydon, Chief Executive Officer
    Posted date: 2021-04-08
    Submission type: Update View updated registration
  • Biogen Canada
    Consultant: Ben Parsons, Counsel Public Affairs Inc.
    Posted date: 2021-04-07
    Submission type: Update View updated registration
  • Biogen Canada
    Consultant: David Murray, Counsel Public Affairs Inc.
    Posted date: 2021-04-07
    Submission type: Update View updated registration
  • Biogen Canada
    Consultant: Sheamus Murphy, Counsel Public Affairs Inc.
    Posted date: 2021-04-07
    Submission type: Update View updated registration
  • HealthCareCAN / SoinsSantéCAN
    In-house Organization: Paul-Émile Cloutier, President and Chief Executive Officer (CEO)
    Posted date: 2021-04-06
    Submission type: Update View updated registration
  • Novo Nordisk Canada Inc.
    In-house Organization: Béatrice Clerc, President
    Posted date: 2021-04-06
    Submission type: Update View updated registration
  • Sanofi Pasteur Limited
    In-house Corporation: Fabien Marino, Vice President, Industrial Affairs and Site Head, Toronto
    Posted date: 2021-03-31
    Submission type: Update View updated registration
  • AstraZeneca Canada Inc.
    In-house Corporation: Jane Chung, President
    Posted date: 2021-03-30
    Submission type: Update View updated registration
  • BAYER INC.
    Consultant: Stephen Sampson, Global Public Affairs
    Posted date: 2021-03-24
    Submission type: Update View updated registration
  • AbbVie Corporation
    Consultant: Jodie Kiss, 3Sixty Public Affairs Inc.
    Posted date: 2021-03-23
    Submission type: New View new registration
  • AbbVie Corporation
    Consultant: WILLIAM DEMPSTER, 3Sixty Public Affairs Inc.
    Posted date: 2021-03-22
    Submission type: New View new registration
  • Cisco Systems Canada Co.
    In-house Corporation: Shannon Leininger, President
    Posted date: 2021-03-19
    Submission type: Update View updated registration
  • Canadian Health Coalition / Coalition canadienne de la santé
    In-house Organization: Steven Staples, National Director of Policy and Advocacy
    Posted date: 2021-03-16
    Submission type: Reactivation View reactivated registration
  • GlaxoSmithKline Inc.
    Consultant: Sheamus Murphy, Counsel Public Affairs Inc.
    Posted date: 2021-03-15
    Submission type: Update View updated registration
  • GlaxoSmithKline Inc.
    Consultant: David Murray, Counsel Public Affairs Inc.
    Posted date: 2021-03-15
    Submission type: Update View updated registration
  • GlaxoSmithKline Inc.
    Consultant: Ben Parsons, Counsel Public Affairs Inc.
    Posted date: 2021-03-15
    Submission type: Update View updated registration
  • Life Sciences Ontario
    Consultant: WILLIAM DEMPSTER, 3Sixty Public Affairs Inc.
    Posted date: 2021-03-10
    Submission type: Update View updated registration
  • Life Sciences Ontario
    Consultant: Philip Delistoyanov, 3Sixty Public Affairs
    Posted date: 2021-03-10
    Submission type: Update View updated registration
  • RAREi - The Canadian Forum for Rare Disease Innovators / iRARE, le Forum canadien des innovateurs spécialisés dans les maladies rares
    Consultant: Johanne Chambers, 3Sixty Public Affairs Inc.
    Posted date: 2021-03-03
    Submission type: Update View updated registration
  • Innovative Medicines Canada
    Consultant: Ikram Farah, Hill & Knowlton Canada
    Posted date: 2021-03-03
    Submission type: New View new registration
  • Innovative Medicines Canada
    Consultant: John Delacourt, Hill+Knowlton Strategies
    Posted date: 2021-03-02
    Submission type: New View new registration
  • GlaxoSmithKline
    In-house Corporation: Faris El-Refaie, President
    Posted date: 2021-03-01
    Submission type: Update View updated registration
  • Takeda Canada Inc.
    Consultant: Patil Imasdounian, Santis Health
    Posted date: 2021-02-24
    Submission type: Update View updated registration
  • Ipsen Biopharmaceuticals Canada Inc.
    Consultant: WILLIAM DEMPSTER, 3Sixty Public Affairs Inc.
    Posted date: 2021-02-17
    Submission type: Update View updated registration
  • Canadian Organization for Rare Disorders
    Consultant: WILLIAM DEMPSTER, 3Sixty Public Affairs Inc.
    Posted date: 2021-02-17
    Submission type: Update View updated registration
  • Takeda Canada Inc.
    Consultant: Ian Chesney, Santis Health
    Posted date: 2021-02-10
    Submission type: Update View updated registration
  • Alexion Pharma Canada
    In-house Corporation: Sean Richardson, Vice President and General Manager, Alexion Pharma Canada
    Posted date: 2021-01-29
    Submission type: Update View updated registration
  • Bayer Inc.
    In-house Corporation: Alok Kanti, President and Chief Executive Officer
    Posted date: 2021-01-19
    Submission type: Update View updated registration
  • 9795855 Canada Inc.
    In-house Corporation: Paul Spark, Consultant
    Posted date: 2021-01-18
    Submission type: Update View updated registration
  • Hoffmann-La Roche Limited
    In-house Corporation: RONNIE MILLER, PRESIDENT AND CHIEF EXECUTIVE OFFICER
    Posted date: 2021-01-11
    Submission type: Update View updated registration
  • Takeda Canada Inc.
    Consultant: Stephanie Gawur, Santis Health
    Posted date: 2021-01-07
    Submission type: Update View updated registration
  • Retail Council of Canada / Conseil canadien du commerce de detail
    In-house Organization: Diane J. Brisebois, President & Chief Executive Officer
    Posted date: 2021-01-06
    Submission type: Update View updated registration
  • Neighbourhood Pharmacy Association of Canada (Neighbourhood Pharmacies) / Association canadienne des pharmacies de quartier
    Consultant: Melissa Pasi, Hill+Knowlton Strategies Canada
    Posted date: 2020-12-15
    Submission type: Update View updated registration
  • Janssen Inc.
    In-house Corporation: Jorge Bartolome, President
    Posted date: 2020-12-15
    Submission type: Update View updated registration
  • Canadian Health Research Forum / Le forum de la recherche canadienne en santé
    Consultant: Philip Delistoyanov, 3Sixty Public Affairs
    Posted date: 2020-11-24
    Submission type: Update View updated registration
  • The Canadian Lung Association / L'Association pulmonaire du Canada
    Consultant: Chris Gray
    Posted date: 2020-11-23
    Submission type: Update View updated registration
  • RAREi - The Canadian Forum for Rare Disease Innovators / iRARE, le Forum canadien des innovateurs spécialisés dans les maladies rares
    Consultant: WILLIAM DEMPSTER, 3Sixty Public Affairs Inc.
    Posted date: 2020-11-12
    Submission type: Update View updated registration
Return to Government Institutions in Active Registrations
Date Modified: